KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Encompass Health (EHC) EBIT (2016 - 2025)

Encompass Health (EHC) has disclosed EBIT for 17 consecutive years, with -$264.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBIT fell 144.9% year-over-year to -$264.7 million, compared with a TTM value of $164.4 million through Dec 2025, down 81.8%, and an annual FY2025 reading of $164.4 million, down 73.72% over the prior year.
  • EBIT was -$264.7 million for Q4 2025 at Encompass Health, down from $179.0 million in the prior quarter.
  • Across five years, EBIT topped out at $880.4 million in Q4 2021 and bottomed at -$264.7 million in Q4 2025.
  • Average EBIT over 5 years is $118.0 million, with a median of $111.4 million recorded in 2022.
  • The sharpest move saw EBIT tumbled 1192.72% in 2021, then surged 21185.71% in 2024.
  • Year by year, EBIT stood at $880.4 million in 2021, then plummeted by 56.71% to $381.1 million in 2022, then plummeted by 65.55% to $131.3 million in 2023, then skyrocketed by 348.97% to $589.5 million in 2024, then plummeted by 144.9% to -$264.7 million in 2025.
  • Business Quant data shows EBIT for EHC at -$264.7 million in Q4 2025, $179.0 million in Q3 2025, and $45.3 million in Q2 2025.